const SampleArticles = {
  MarketWatch: {
    siteName: "MarketWatch",
    featuredArticle: {
      image:
        "https://images.mktw.net/im-261569?width=1260&size=1.5005861664712778",
      title:
        "Pfizer says it will seek U.S. emergency-use authorization within days for coronavirus vaccine",
      body:
        "Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that the vaccine protects older people most at risk of dying from COVID-19.The announcement, just a week after Pfizer PFE, 2.47% first revealed promising preliminary results, comes as the company is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.",
    },
    secondaryArticles: {
      secondaryArticle1: {
        image:
          "https://images.mktw.net/im-261567?width=1260&size=1.44960362400906",
        title:
          "U.S. stocks turn mixed early Wednesday even as vaccine optimism remains a central theme ",
      },
      secondaryArticle2: {
        image:
          "https://images.mktw.net/im-261099?width=1260&size=1.4988290398126465",
        title:
          "Opinion: Put bank stocks in the ‘buy’ pile if you think a coronavirus vaccine will help mend the economy",
      },
      secondaryArticle3: {
        image:
          "https://images.mktw.net/im-261543?width=1260&size=1.5005861664712778",
        title:
          "George Soros laments investment in Palantir and says he will sell the rest when allowed",
      },
      secondaryArticle4: {
        image:
          "https://images.mktw.net/im-239756?width=1260&size=1.44960362400906",
        title:
          "Opinion: Now that Tesla is joining the S&P 500, you might want to sell",
      },
      secondaryArticle5: {
        image:
          "https://images.mktw.net/im-260580/horizontal?width=1260&size=1.778975741239892",
        title:
          "The weirdest sign of COVID-19 fatigue? More Americans are grinding their teeth ",
      },
    },
  },
  YahooFinance: {
    siteName: "Yahoo Finance",
    featuredArticle: {
      image:
        "https://s.yimg.com/ny/api/res/1.2/Ul_x2L.94WPRfW0TaSchfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTYzOS4xNjg5OTcyMDMzNTY-/https://media-mbst-pub-ue1.s3.amazonaws.com/creatr-uploaded-images/2020-11/25ad2330-2923-11eb-afff-1c6a67bb1883",
      title:
        "Stock market news live updates: Dow rises after more positive vaccine trial data",
      body:
        "Stocks mostly rose Wednesday morning after new data from Pfizer (PFE) helped stoke investor confidence that an effective vaccine will become available in the coming months.The pharmaceutical company reported Wednesday that it had concluded its Phase 3 trial of its vaccine candidate, and found its inoculation to be 95% effective against COVID-19. A week earlier, with fewer participants with confirmed cases of COVID-19 were available to analyze, Pfizer had said its vaccine candidate was “more than 90% effective.” Pfizer added Wednesday it now has the safety data required to be able to submit for emergency use authorization with the Food and Drug Administration “within days.”The Dow jumped about 50 points, or 0.2%, amid the news.",
    },
    secondaryArticles: {
      secondaryArticle1: {
        image:
          "https://s.yimg.com/ny/api/res/1.2/cnaYTJ0ZiQe2WLT9qCHcAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media-mbst-pub-ue1.s3.amazonaws.com/creatr-uploaded-images/2020-11/2ad57a90-299d-11eb-bf8e-b90b8541cfab",
        title:
          "Post-Christmas jobless benefits expiration 'threatens to pull the rug out from under' the U.S. economy",
      },
      secondaryArticle2: {
        image: "https://images.barrons.com/im-261608?width=1260&size=1.5",
        title: "Carnival and Norwegian Cruise Line Are Selling More Stock",
      },
      secondaryArticle3: {
        image:
          "https://s.yimg.com/ny/api/res/1.2/zFkDlsUkWvF67vIu.SZOGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MS40NjAzMTc0NjAzMTc1/https://s.yimg.com/uu/api/res/1.2/rUA67Amu5xrdjDWX.KfHmg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/03b971cb37e1840380728e73ac1cf03c",
        title:
          "Dow Jones Stocks To Buy And Watch In November 2020: Apple, Microsoft Offer New Buy Points",
      },
      secondaryArticle4: {
        image:
          "https://s.yimg.com/ny/api/res/1.2/4wRsaCKbFHNHCPm5Anqp2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0Mi42MDg2OTU2NTIxNzM5/https://s.yimg.com/uu/api/res/1.2/cIIUtm8Qj8YxKbv4dIbdQA--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/398657da8deaf35f442b3df69622839e",
        title:
          "Is Nio Stock A Buy Right Now As Chinese EVs Boom? Here's What Earnings, Stock Chart Show",
      },
      secondaryArticle5: {
        image:
          "https://s.yimg.com/ny/api/res/1.2/uykW8Z8r9IHnP4cCsOzG6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTYzOS44NA--/https://s.yimg.com/uu/api/res/1.2/lr1ln4nwTkIVpC47cMxZzQ--~B/aD0xMzMzO3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_markets_842/c6bb5e1b9f24e217752e500c32aa2bde",
        title:
          "U.S. Stocks Mixed as Investors Weigh Covid Outlook: Markets Wrap",
      },
    },
  },
  GoogleFinance: {
    siteName: "Google Finance",
    featuredArticle: {
      image:
        "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSvwzlEFVGtQT4L8ni-1FunYATE7GoYWbMGA1WG2oEqa0vM0HFoO8BiCXI5vv4",
      title:
        "Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns",
      body:
        "A final analysis of the Phase 3 trial of Pfizer’s coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, the company said Wednesday.The company counted 170 cases of coronavirus infection among volunteers who took part in the trial. It said 162 infections were in people who got placebo, or plain saline shots, while eight cases were in participants who got the actual vaccine.",
    },
    secondaryArticles: {
      secondaryArticle1: {
        image:
          "https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcTG7nqURbkzBtut8j8NiO2YVk3avJgH1Ao4BngRo5RfEiAYRwzMukSK4F0tXro",
        title:
          "Stocks making the biggest moves in the premarket: Target, Lowe's, Apple, Boeing, Pfizer & more",
      },
      secondaryArticle2: {
        image:
          "https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcR6sZmiVBm3Mf8lyMcDgZdkXNs8WylyfSSmv6BGO_BoIsbzyr-MLfRdfnfSlYM",
        title: "Marissa Mayer is back and she wants to fix your address book",
      },
      secondaryArticle3: {
        image:
          "https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcQHIYTTDjikfBVvL11hvQfxEfJv6V4fWUUax-zLesc5szhbTUQY3lar2BTPHao",
        title:
          "Oh God, the Worst Passwords of 2020 Are Here and They're Horrifying",
      },
      secondaryArticle4: {
        image:
          "https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcQDpgZrO6V2P0PwfAMVAVT1BS7y5kBHOivOivdQoSs4R-MXpS0QQEIQo-VEuNI",
        title: "2022 Honda Civic proves compact sedans aren't dead yet",
      },
      secondaryArticle5: {
        image:
          "https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcSgdeftepxlgXOpdKTFKCRhuLxzkENiRbThm20QvJjrmxfmluTcjM2F6E1GXqY",
        title: "We're never going back to the old economy, Fed Chairman says",
      },
    },
  },
};

export default SampleArticles;
